Contributing Author: Chris Mycek, President at WORLEY Pivoting to virtual….Google it, you’ll find it’s a common current theme that will have enduring repercussions on how things get done. Zoom is a new household word, and now a verb as well. Amazon Prime, Netflix, FedEx, are all booming. Nesting at home, with new entertainment centers, pools, and other home luxuries are also … [Read more...]
COVID-19 Accelerates Digital Transformation in Life Sciences
Author: Andy Fuchs, VP of Commercial Strategy, Veeva Systems Public safety is the world’s singular goal as mandatory quarantines, shelter-in-place orders, travel restrictions, and mandatory work-from-home policies go into effect to curb the spread of COVID-19. In response, many biopharmaceutical companies are shifting how they work: Amarin withdrew part of its field force, … [Read more...]
Veeva Introduces Payment Solution for Clin Research Sponsors/CROs and Sites
The success of clinical trials depends on an adequate supply of experienced clinical site investigators. However, the pool of qualified investigators has been shrinking in recent years and a growing proportion of “one-and-done” investigators stop leading clinical trials after one trial. Nearly one-third (30%) of all sites engaged in research currently are first timers. The loss … [Read more...]
Optimizing the Precision Blending of Pharmaceutical Tablets
Contributed by: Leslie Taylor, Power PR. 310-787-1940 ext 419. [email protected] Tumble blender technology enhances the speed and homogeneous blending of tablets and capsules with trace levels of additives To meet stringent regulatory requirements, such as the United States Pharmacopeia (USP), National Formulary (NF) or FDA, as well as production and budgetary demands, … [Read more...]
The Next Wave of Patient Centricity
Listening to the voice of the patient provides insights that can inform every stage of a pharma company’s business, from drug discovery to winning regulatory approval to post-market disease management. This can help the company bring drugs to market that reflect patient needs, align with the reward-for-outcomes that governments and payers require, and help patients and … [Read more...]